GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
99 hedge funds and large institutions have $239M invested in GenMark Diagnostics, Inc in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
+3
Holders Change %
+3.13%
% of All Funds
2.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
36
Reduced
24
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.31M |
| 2 |
CC
Casdin Capital
New York
|
+$5.13M |
| 3 |
CCM
Cadian Capital Management
New York
|
+$4.11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.36M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.29M |
Top Sellers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$21.4M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$15M |
| 3 |
Jennison Associates
New York
|
-$7.72M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$4.23M |
| 5 |
Millennium Management
New York
|
-$3.61M |
